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To the Editor,
We have previously reported that mice lacking three compo-
nents of the epidermal corniﬁed envelope – Envoplakin, Periplakin
and Involucrin – (EPI/ mice) exhibit several hallmarks of atopic
dermatitis and are resistant to developing chemically induced skin
tumours [1,2]. EPI/ mice have an enhanced skin bacterial load
and exhibit upregulation of a variety of anti-microbial proteins
(AMPs), including b-defensins and S100A9 [3].
When analysing a previously published dataset of genes that
are differently expressed in the skin of EPI/ and wild type (WT)
mice, we noticed a more than 3-fold increase in expression of
Galectin-6 [2]. Galectins are a family of lectins with binding
speciﬁcity for b- galactosides [4]. Although the function of
Galectin-6 has not been characterized, several galectin family
members have antimicrobial activity, targeting blood group
positive microbes [5]. This led us to hypothesise that Galectin-6
is a novel skin AMP.
When EPI/ mice are housed under conventional conditions,
the skin microbiota, as quantitated by 16 S ribosomal RNA levels, is
approximately three-fold more abundant than in WT controls [3]
(see Supplementary Information for details of mice and experi-
mental techniques). However, when EPI/ mice are housed
under speciﬁc pathogen-free (SPF) conditions the bacterial load
falls to that of WT mice [3]. We conﬁrmed that Galectin-6 mRNA
was signiﬁcantly higher in EPI/ mice (Fig. 1A). Furthermore, in
contrast to the AMPs analysed previously [3], Galectin-6 expres-
sion was decreased in the skin of EPI/ mice housed under SPF
conditions (Fig. 1A).
By comparing levels of Galectin-6 in total skin, from which the
adipocyte layer had been removed, and epidermis, we could showAbbreviations: EPI/, lacking Envoplakin, Periplakin and Involucrin; AMPs,
anti-microbial proteins; WT, wild type; SPF, speciﬁc pathogen-free; GST, Glutathi-
one S-transferase.
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the CC BY license (http://creativecommons.org/licenses/by/4.0/).that Galectin-6 is more abundant in the dermis than the epidermis
(Fig. 1A). This is of interest, given that bacteria can penetrate the
living epidermal layers in EPI/ mice [3]. Since galectin-6 gene
expression in WT skin was not altered when WT mice were housed
under SPF conditions (Supplementary Fig. 1), galetin-6 is likely to
respond to an abundant skin ﬂora when the epidermal barrier is
defective, but not to microbial load under steady state conditions.
Amongst galectin family members, galectin-4 shares more than
80% sequence homology with galectin-6. Lgals6 represents a
duplication of the galectin-4 gene, and the two genes share 8 out of
10 exons [6]. However, expression of other galectins, including
galectin-4, did not differ between EPI/ and WT whole skin,
irrespective of whether or not the EPI/ mice were maintained
under SPF conditions (Fig. 1B).
Given its unusual expression in EPI/ skin, we investigated
whether Galectin-6 has anti-microbial activity. A range of bacterial
strains were grown in the presence of recombinant Galectin-6 or
control protein expressing GST tag only. As previously reported for
Galectin-4 and Galectin-8 [7], Galectin-6 suppressed the growth of
E. coli expressing blood group antigen (E. coli O86, possessing
blood group-B antigen), in a dose-dependent manner (Fig. 1C), and
did not affect the growth of non-blood group antigen-expressing E.
coli or other bacterial strains tested (Fig. 1D). The antimicrobial
activity of galectin-6 was similar to that of murine galectin-4
(Supplementary Fig. 2). We conclude that Galectin-6 is a novel
AMP, the expression of which can be modulated by skin bacterial
load.
Galectin-6 differs from the other AMPs we have examined in
being regulated by bacterial load in EPI/ skin. This is all the more
remarkable, given that its abundance is low in the epidermis
relative to total skin. Lgals6 is also unusual in that it does not have a
human homologue and is present in some mouse species,
including 129sv, but not in others, such as C57BL/6 and Balb/c
[6]. Even though Galectin-4 and Galectin-6 are highly conserved,
their expression patterns in the digestive tract differ following
challenge with dextran sodium sulfate [8]. This is consistent with
the differential regulation of Lgals6 and Lgals4 by the skin
microbiota. Furthermore, previously published microarray data
show that Lgals4 expression is not signiﬁcantly altered in atopic
dermatitis and psoriatic skin compared with normal controls
(GSE26952) [9]. We cannot exclude the possibility that skin barrier
defects also contributed to the upregulated expression of Lgals6 in
EPI/ mice, because the level in ﬂora-deﬁcient EPI/mice was
still higher than that of controls. Nevertheless, our ﬁndings reveal
that Galectin-6, unlike other AMPs [3], is inﬂuenced by the
abundance of skin microbiota. We also do not rule out additional
functions for Galectin-6 in the skin; for example in the dermis it
could potentially modulate ﬁbrosis, as in the case of galectin-3 in
the lung [10].Japanese Society for Investigative Dermatology. This is an open access article under
Fig. 1. Lgals6 expression and function in skin (A) qRT-PCR of Lgals6 in WT, EPI/ and ﬂora-deﬁcient EPI/ skin and epidermis. (B) qRT-PCR of genes encoding other
galectins (Lgals1, Lgals3, Lgals4, Lgals7, Lgals8, Lgals9 and Lgals12) in WT, EPI/ and ﬂora-deﬁcient EPI/ whole skin. Data are means  SEM from at least 4 mice per group.
(C) Antimicrobial properties of recombinant galectin-6 (closed circles) or tag protein (open squares) on blood group antigen-expressing E.coli (O86) growth. (D) Growth of
non-blood group antigen-expressing E.coli (O6), P. aeruginosa, S. epidermidis and S. aureus treated with the recombinant galectin-6 or tag protein. See supplemental
information for methodology and reagents. P-values are indicated with: * p < 0.05, *** p <0.001.
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Changes in tight junction protein expression in
intrinsic aging and photoaging in human skin in
vivo
Tight junctions (TJs) exist in a planar network and function as
barriers that seal the intercellular space between epithelial cells to
prevent water loss [1]. TJs contain protein complexes, are situated
in the epidermal granular layer, and are composed primarily of
claudins, occludin, and ZO proteins, which act in a systematic
manner and regulate TJ function [1]. In addition to their role as
water barriers, bidirectional paracellular penetration of ions and
proteins is possible through TJs. Moreover, in response to various
environmental stresses, TJs are dynamically regulated and interact
with Langerhans cells [2]. Skin aging is a complex process induced
by intrinsic and/or extrinsic factors, like ultraviolet (UV) radiation,
and is accompanied by physiological changes in the skin that
involve impaired barrier function [1]. Since changes in major TJ
components in aged skin have not been characterized, we aimed to
elucidate changes in TJ protein expression in intrinsic aging and
photoaging.
To examine effects of aging on TJs, expression of three major TJ
components (claudin-1, occludin, and ZO-1) was evaluated in
intrinsically aged and photoaged human skin. Photoprotected
buttock and photoaged forearm skin tissues were collected from
elderly volunteers (n = 5, median age: 77 years, interquartile range:
75–81) and young volunteers (n = 5, median age: 28 years,
interquartile range: 26–31). Because TJs also exist in endothelial
cells in the dermis, the epidermis was separated from the dermis
by incubating whole skin tissue at 55 C in phosphate-buffered
saline (PBS) for 2 min and physically peeling off the epidermis.
Western blotting and quantitative polymerase chain reaction (PCR)
were performed using the epidermis, and immunoﬂuorescence
(IF) staining was conducted using the whole skin. IF data were
graded according to the intensity within the granular layer by three
expert dermatologists who were blinded to the identity of each
image. This study was approved by the Institutional Review Board
at Seoul National University Hospital, and was conducted
according to the Declaration of Helsinki; written informed consent
was received from all subjects.
In intrinsically aged skin, claudin-1 and occludin were
signiﬁcantly downregulated, as shown by western blotting and
immunostaining. However, their mRNA levels were not signiﬁ-
cantly altered (Fig. 1A and B). The staining intensity and area of
claudin-1 expression were markedly reduced in samples from
elderly participants than in those from young participants.Speciﬁcally, within the granular layer, claudin-1 was also
signiﬁcantly decreased in samples from elderly subjects
(Fig. 1C). However, there were no signiﬁcant differences in ZO-1
protein expression between young and aged samples.
To investigate the inﬂuence of photoaging on TJs, we compared
TJ protein expression in buttock skin with that in matched forearm
skin from the same elderly subjects. Claudin-1 expression was
signiﬁcantly decreased at both protein and mRNA levels (Fig. 2A
and B). Immunostaining also revealed that claudin-1 was reduced
more in photoaged skin than in intrinsically aged skin; thus,
claudin-1 was detected sparsely within the upper suprabasal
layers in photoaged skin of elderly individuals (Figs. 1C and 2C). In
contrast, no signiﬁcant changes were found between buttock and
forearm skin from young individuals (Fig. S1). Photoaged skin
exhibited greater decreases in claudin-1 expression compared to
intrinsically aged skin (84.9% versus 56.2% reduction, respectively).
The other two proteins, occludin and ZO-1, did not show any
signiﬁcant changes in photoaged skin.
We found that claudin-1 was reduced in both intrinsically aged
and photoaged human skin in vivo. Despite the uncertain role of
occludin in barrier function, claudin-1 is known to be important in
the formation of functional TJs and recruitment of occludin to TJs,
suggesting that impaired claudin-1 expression in aged skin causes
the loss of TJ functionality [3]. Moreover, recent reports have
shown that there is a close association between TJs and the
stratum corneum (SC) and have suggested that the former is
responsible for the formation of a complete SC barrier [4,5].
Speciﬁcally, patients suffering from claudin-1-null mutations
show ichthyotic, xerotic, and ﬂaky skin [5]. Moreover, claudin-1
is essential to ﬁlaggrin processing [4]; thus, claudin-1-knockout
mice show decreased levels of ﬁlaggrin monomer, which is
important for maintaining skin hydration and barrier integrity [2].
Similarly, elderly individuals show substantially reduced expres-
sion of ﬁlaggrin protein, but not mRNA, in the skin [6]. Expression
proﬁles of epidermal TJ proteins associated with aging or UV
irradiation have been controversial. While some investigators have
reported that claudin-1 is increased after single UVB irradiation of
7.5 minimal erythema dose to hairless mice [7], others have shown
that UVB irradiation does not change claudin-1 expression in
cultured keratinocytes [8]. In contrast, claudin-1 expression is
decreased following UV irradiation for 5 consecutive days in 24-
week-old mice [9]. Furthermore, Rachow et al. showed that sun-
exposed skin exhibits reduced expression of claudin-1, particularly
in the lowermost epidermal layers [10]. However, they used
clinical samples from participants of varying ages (sun-exposed
skin, age 16–89 years, mean 67 years; sun-protected skin, age 20–
78 years, mean 42 years) and locations (sun-exposed skin from
face and forearm; sun-protected skin from abdomen) and did not
show actual immunostaining images. We demonstrated changes
in TJ proteins in homogenous age groups and locations and
compared photoaged skin with intrinsically aged skin from the
same individuals. Moreover, to avoid possible misleading effects
